86 SERUM HYALURONIC ACID (HA) – A NEW TEST OF LIVER FUNCTION?
نویسندگان
چکیده
منابع مشابه
Serum Hyaluronic Acid (HA) and Soluble Intercellular Adhesion Molecule-
Schistosomiasis mansoni is a chronic liver disease that is endemic in rural areas of Egypt. Some patients may acquire infection and develop minimal complications, while others may develop severe complications and progress to portal hypertension and cirrhosis, especially if coinfected with viral hepatitis [1,2]. Egypt has the highest worldwide prevalence for the concomitant infection of schistos...
متن کاملSerum hyaluronic acid and laminin as biomarkers in liver fibrosis.
BACKGROUND AND AIM Non-invasive methods have been proposed as surrogate markers for liver biopsy. It was shown that serum hyaluronic acid (HA) and laminin (LN) levels increase with the development of liver fibrosis. The aim of this study was to determine serum HA and LN levels cut-off points for predicting liver fibrosis, highlighting their diagnostic value and their changes during treatment. ...
متن کاملASSISTED REPRODUCTION Efficiency of hyaluronic acid (HA) sperm selection
Purpose Hyaluronic Acid (HA) has a role as “physiologic selector” for spermatozoa prior to intracytoplasmic sperm injection (ICSI). The objective of this study is to analyze the results achievable by the introduction of a routine HA-ICSI programme. Methods We retrospectively observed 293 couples treated with HA-ICSI versus 86 couples treated with conventional PVP-ICSI (historical control group)...
متن کاملA new liver function turbidity test.
The various liver flocculation tests proposed in recent years by several investigators cannot be considered as specific, hence clinicians tend to use many of them simultaneously. Obviously, the simplicity and the rapidity with which any one of these tests can be performed are essential advantages. The following new liver function turbidity test is simple and rapid, and is more sensitive than th...
متن کاملThe double glucagon test, a new liver function test.
A double glucagon test was performed in 100 patients and seventeen control subjects. Two intravenous doses of glucagon (1 mg) were administered at a 1-hr interval. Glucose was determined before the first injection and 20, 25 and 30 min after both doses, and the increases after each successive dose were added up. In normal persons, the total increase in glycaemia was higher in the second than in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1988
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-198809000-00109